IRONWOOD PHARMACEUTICALS INC (IRWD) — Institutional Holders, Q2 2026 (page 3)

212 institutional investment managers reported a IRWD position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $675.8M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 212. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

IRWD 13F holders ranked 201–212 of 212

Institutional investors reporting a position in IRONWOOD PHARMACEUTICALS INC on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
NATIONAL BANK OF CANADA#201 · 136 sh$573.00-99.7%
Wealth Enhancement Services#202 · 119 sh$501.00New
Clean Yield Group#203 · 85 sh$358.000.0%
Clearstead Advisors#204 · 73 sh$308.00New
Keating Financial Advisory Services#205 · 66 sh$278.000.0%
Ronald Blue#206 · 34 sh$143.000.0%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT#207 · 29 sh$119.00New
Steward Partners Investment Advisory#208 · 17 sh$72.00-99.8%
Ritter Daniher Financial Advisory / DE#209 · 6 sh$26.00New
Walleye Capital#210 · 1 sh$4.00-100.0%
Smartleaf Asset Management#211 · 1 sh$4.000.0%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#212 · 2,241 sh—-74.1%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.